Matinas Biopharma Holdings, Inc.盘中异动大幅跳水5.09%

自选股智能写手03-13

北京时间2024年03月13日00时13分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现波动，股价急速下跌5.09%。截至发稿，该股报0.257美元/股，成交量13.6887万股，换手率0.06%，振幅6.35%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.06百万美元，每股收益-0.03美元，毛利-238000.00美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2419575685?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-13 00:13","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2419575685","market":"us","top_or_hot":-1,"title":"Matinas Biopharma Holdings, Inc.盘中异动 大幅跳水5.09%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年03月13日00时13分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现波动，股价急速下跌5.09%。截至发稿，该股报0.257美元/股，成交量13.6887万股，换手率0.06%，振幅6.35%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.06百万美元，每股收益-0.03美元，毛利-238000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031300130887e783cd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Matinas Biopharma Holdings, Inc.盘中异动 大幅跳水5.09%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMatinas Biopharma Holdings, Inc.盘中异动 大幅跳水5.09%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-13 00:13 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031300130887e783cd&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年03月13日00时13分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现波动，股价急速下跌5.09%。截至发稿，该股报0.257美元/股，成交量13.6887万股，换手率0.06%，振幅6.35%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.06百万美元，每股收益-0.03美元，毛利-238000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031300130887e783cd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MTNB","symbol_name":"Matinas BioPharma Holdings, Inc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031300130887e783cd&s=b","article_id":"2419575685","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031300130887e783cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2419575685","pubTimestamp":1710259987,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年03月13日00时13分，Matinas Biopharma Holdings, Inc.股票出现波动，股价急速下跌5.09%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，致力于发现和开发源自其脂质晶体纳米颗粒或耳蜗递送技术平台的候选产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"MTNB":"Matinas BioPharma Holdings, Inc","BK4139":"生物科技"},"translate_title":"Matinas Biopharma Holdings, Inc. plunged 5.09% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MTNB":0.9},"content_text":"北京时间2024年03月13日00时13分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现波动，股价急速下跌5.09%。截至发稿，该股报0.257美元/股，成交量13.6887万股，换手率0.06%，振幅6.35%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.06百万美元，每股收益-0.03美元，毛利-238000.00美元，市盈率-2.64倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。其相关个股中，Regulus Therapeutics Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 (To Pur Com)、Ys Biopharma Co Ltd C/Wts 15/03/2028 (To Pur Ord)涨幅较大，Regulus Therapeutics Inc.、Tc Biopharm (Holdings) Plc、Scisparc Ltd.较为活跃，换手率分别为619.24%、294.18%、161.59%，振幅较大的相关个股有Regulus Therapeutics Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 (To Pur Com)、Carmell Corp C/Wts 12/07/2028 (To Pur Com)，振幅分别为131.16%、74.77%、59.72%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，致力于发现和开发源自其脂质晶体纳米颗粒或耳蜗递送技术平台的候选产品。 该公司的产品线包括MAT2203，MAT2501等。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2419575685"}

Matinas Biopharma Holdings, Inc.盘中异动 大幅跳水5.09%

精彩评论

Matinas Biopharma Holdings, Inc.盘中异动大幅跳水5.09%